Founded in 1994, BioChain, headquartered in the San Francisco Bay Area, has become the world leader in biospecimen sample collection, processing, and services enabling biomarker discovery, translational research, and clinical product development and commercialization.
With over a decade of development and primary focus on quality and cost efficiency, BioChain has become a brand name and a reliable resource for our growing list of customers and partners.
From our ISO 9001:2008 certified production facility, we offer a comprehensive list of molecular biology and genomics products developed in-house or licensed from our partners, including the hot-selling matched pairs of tumor and normal control samples, frozen or FFPE tissue arrays, ultraspeed cloning checker, gDNA controls, kit for isolating DNA, RNA and protein simultaneously from the same biological sample, as well as our recently launched qPCR and RNA-seq next-generation sequencing products. We are the powerhouse in supplying biospecimen samples and analysis tools with unprecedented efficiency and cost effectiveness.
Addressing unmet customer needs through innovation is the guiding principle behind our growth strategy. In addition to our well established Bio Specimen business our clinical application direction is set to develop clinical genomics diagnostics and clinical trial services in gynecological oncology and reproductive health.
We are proud to be part of the biomedical community that is significantly improving the length and quality of people's lives.
Vision & Mission
Our mission is to create, develop, and deliver value-added biospecimen processing, analysis and diagnostic products to enable genomic biomarker discovery and drug/ diagnostics development.
BioChain (Beijing) Science & Technology. Inc, which was established in August 2006 by investment of BioChain research institute centre and located in the Beijing Open economic & technological zones, is one of the national high technology and development enterprises and is authorized as Beijing scientific and technological organization for research and development by Committee of science and technology of Beijing. The company provides high quality service of technological development for national universities and colleges, hospitals and international pharmaceutical companies. Accompanied with gradually deep cooperation, we establish strategical relations with many top ranking national hospitals. The mainly business of the company including: clinical research service, clinical detection service, clinical diagnostic reagents and clinical research reagents.
Beijing Modern Gaoda Biotechnology Co., Ltd (MGBC) is a leading provider of biomedical in vitro diagnostic products in China, which was established in 1993. With long-term and continuous efforts, we have developed a unique one-stop solution which enables us to bring customers the high quality products and best service from R & D, manufacturing, logistics and sales in biomedical industry. MGBC has a group of experienced scientific researchers and possesses a solid R&D ability. Our company also keeps good cooperation with several domestic and international well-known companies and institutions. We expend our product lines rapidly to meet the different needs of customers. At present, we are capable to produce high-quality Prenatal and Newborn test, Blood Screening test, Hepatitis test, Tumor Marker test, Colloidal gold rapid test etc. 5 series and 30 specifications are available. Meanwhile, we have obtained 5 Drug Registration Certificates and 15 medical device registration certificates issued by the SFDA.